650-P: An Audit of the Clinical Outcomes of DAFNE Singapore (2011-2018)

Autor:	Sarah Tan, Suresh Chandran, Daphne Gardner, Huee Boon Lim, Su-Yen Goh, Kala Adaikan
Rok vydání:	2019
Předmět:	medicine.medical_specialty Dose business.industry Endocrinology Diabetes and Metabolism Insulin medicine.medical_treatment Audit medicine.disease INSULIN USE Diabetes mellitus Internal medicine Internal Medicine Chi-square test Asian country Medicine DAFNE business
Zdroj:	Diabetes. 68
ISSN:	1939-327X 0012-1797
DOI:	10.2337/db19-650-p
Popis:	Background: The Dose Adjustment for Normal Eating (DAFNE) is a type 1 diabetes (T1D) group education program to enable self-management. Shown to improve outcomes in the UK, its application in Asian countries remains uncertain. We assessed the outcomes of Singapore (Sg)DAFNE, which remains the only Asian centre, from 2011-2018. Methods: Prior to DAFNE entry, most had received one-on-one education from DAFNE educators. HbA1c, total daily dose (TDD) of insulin were retrieved at these timepoints: 1y before, at entry, 1y after, latest profile. Paired sample t-tests and Chi square tests were used; data is presented as means±SD. Results: n=115 (33.9% male), age 28.3±8.5y, T1D duration 11.2± 8.4y, follow-up post-DAFNE 3.5 ±2.3y. n=104 completed 1y follow-up post-DAFNE. Mean HbA1c pre-DAFNE fell by entry into DAFNE: pre-vs.-entry: 8.5±1.68% (68 mmol/mol) vs. 7.9±1.4%, p Conclusion: This demonstrates the effectiveness of SgDAFNE. Sustained improved glycaemic control was achieved with reduced insulin dosages, reinforcing that the quality of insulin use matters more than the quantity. Disclosure S. Tan: None. S. Rama Chandran: None. H. Lim: None. K. Adaikan: None. S. Goh: None. D. Gardner: None.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4649f04c8c112432114db9930ce7abc4 https://doi.org/10.2337/db19-650-p Zobrazit plný text záznamu